Healthcare leaders, federal policy makers, academic leaders, consumer and patient advocacy groups, and others with an interest will hear from recognized experts in the area of personalized health care. Industry leaders will discuss leveraging scientific discoveries from genomics and DNA research to improve health care outcomes and effectiveness.
“We are in the midst of a transformation in medicine and this year’s conference explores many of those changes, along with the great potential for predictive, preventive, personalized and participatory health care,” says Dr. Clay Marsh, executive director of the OSU Center for Personalized Health Care. “At the same time, we are providing a timely forum to address many issues high on the agenda of the current policy reform debate,” adds Marsh, who also is senior associate vice president for research in the Office of Health Sciences, and vice dean for research in the College of Medicine.
With a conference theme of “Transforming Health Care Through Personalized Medicine,” participating speakers include Dr. Leroy Hood, president, Institute for Systems Biology; Dr. Ralph Snyderman, chancellor emeritus, Duke University Medical System; Dr. Daniel Levy, director, Framingham Heart Study, and professor of medicine, Boston University School of Medicine; and Lawrence Lesko, director, Office of Clinical Pharmocology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration.
Speakers and expert panels will discuss the role of academic medical centers in advancing personalized health care in both research and clinical practice; personalized medicine and participatory health care; population genetics and heart risk profiling; developing a medicine model to advance personalized health care; how the patient-centered medical home model can improve patient health and strengthen the healthcare delivery system; consumer genetics, ethics and genetic counseling; developing a personalized cancer care policy agenda and its implications for health care reform; personalized cancer care – targeted therapeutics for diagnosing and treating hematological malignancies; and pharmacogenomics in clinical medicine.
Personalized health care utilizes gene-based information to understand each person’s individual requirements for maintaining their health, preventing disease and tailoring therapies. It incorporates knowledge of an individual’s environment, health-related behaviors, culture and values.
Complete information about the conference program, including registration and keynote speakers, is available at http://www.ced.osu.edu/PersonalizedHealthCare/.
Contact: Doug Flowers, Medical Center Communications, (614) 293-3737, or Doug.Flowers@osumc.edu
12V, 48V, high-voltage – trends in E/E automotive architecture
10.01.2017 | Haus der Technik e.V.
2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover
09.01.2017 | Technische Informationsbibliothek (TIB)
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
18.01.2017 | Power and Electrical Engineering
18.01.2017 | Materials Sciences
18.01.2017 | Life Sciences